{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T18:31:29Z","timestamp":1698690689587},"reference-count":36,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,12,20]],"date-time":"2002-12-20T00:00:00Z","timestamp":1040342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2003,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background:<\/jats:bold> In Iran, there is insufficient information on the efficacy of <jats:italic>Helicobacter pylori<\/jats:italic> eradication regimens shorter than 10 days. This study aims at assessing the efficacy of 4\u2010 and 7\u2010day <jats:italic>H.\u2003pylori<\/jats:italic> eradication regimens in a high\u2010incidence area of gastric cancer in Iran.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Subjects with an endoscopic diagnosis of gastritis, positive urease test, and a histological diagnosis of chronic gastritis were enrolled. Patients were randomly assigned to one of three groups: AOC7 (1000\u2003mg amoxicillin, 20\u2003mg omeprazole, and 500\u2003mg clarithromycin twice daily for 7\u2003days), FOT4 (200\u2003mg furazolidone, 20\u2003mg omeprazole, and 500\u2003mg tetracycline twice daily for 4\u2003days) and FOT7 (the same treatment as the FOT4 group but for 7\u2003days). Sensitivity to these antibiotics was determined in all isolates recovered from culture. The efficacy of eradication was assessed 8\u2003weeks after the end\u2010of\u2010treatment by the <jats:sup>14<\/jats:sup>C\u2010urea breath test.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> One hundred and twenty\u2010eight patients were enrolled in the study. Culture was positive for 84 patients and none of these were resistant to amoxicillin, tetracycline or furazolidone, 1.2% were resistant to clarithromycin and 32.1% to metronidazole. Forty\u2010five, 41 and 42 patients were randomly allocated to the AOC7, FOT4, and FOT7 groups, respectively. The intention\u2010to\u2010treat eradication rates were 35.5, 17.1, and 23.8% for the AOC7, FOT4, and FOT7 groups, respectively.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Treatment regimens of 4 or 7\u2003days are unacceptable for <jats:italic>H.\u2003pylori<\/jats:italic> infection in Iran, even in the presence of a favorable sensitivity profile.<\/jats:p><jats:p>\u00a9 2003 Blackwell Publishing Asia Pty Ltd<\/jats:p>","DOI":"10.1046\/j.1440-1746.2003.02897.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T05:23:38Z","timestamp":1047446618000},"page":"13-17","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Low <i>Helicobacter pylori<\/i> eradication rates with 4\u2010 and 7\u2010day regimens in an Iranian population"],"prefix":"10.1111","volume":"18","author":[{"given":"REZA","family":"MALEKZADEH","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHAHIN","family":"MERAT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MOHAMMAD\u2010HASSAN","family":"DERAKHSHAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FARIDEH","family":"SIAVOSHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ABBAS","family":"YAZDANBOD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JAVAD","family":"MIKAELI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RASOUL","family":"SOTOUDEMANESH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASOUD","family":"SOTOUDEH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MOHAMMAD\u2010JAFAR","family":"FARAHVASH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SIAVOSH","family":"NASSERI\u2010MOGHADDAM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AKRAM","family":"POURSHAMS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHAHAB","family":"DOLATSHAHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BEHNOOSH","family":"ABEDI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MASOUD","family":"BABAEI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHAHNAM","family":"ARSHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ALI","family":"MAJIDPOUR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,12,20]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"116","article-title":"Helicobacter pylori","volume":"89","author":"Marshall BJ","year":"1994","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199110173251611"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa001999"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200109133451111"},{"key":"e_1_2_6_6_2","first-page":"58","volume-title":"Epidemiology of cancer of the digestive tract","author":"Correa PP","year":"1998"},{"key":"e_1_2_6_7_2","unstructured":"ParkinDM MujirCS WhelanSL GaoYT FerlayJ PowellJ eds.Cancer Incidence in Five Continents Vol.6. IARC Scientific Publication No. 120 Lyon:1992;865\u201370."},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(71)90065-8"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2000.02229.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00879.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00744.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00540.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00827.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-5378.1998.08019.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200108000-00007"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1998.tb04452.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00892.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00931.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1128\/jcm.34.5.1232-1234.1996","article-title":"Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a mini\u2010well format","volume":"34","author":"Vasquez A","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.6.1230"},{"key":"e_1_2_6_21_2","first-page":"60","article-title":"Susceptibility of various strains of Helicobacter pylori to selected agents","volume":"3","author":"Siavoshi F","year":"2000","journal-title":"Arch. Intern. Med."},{"key":"e_1_2_6_22_2","first-page":"1027","article-title":"Mini\u2010dose (1 micro\u2010ci) 14C urea breath test for detection of Helicobacter pylori","volume":"89","author":"Raju GS","year":"1994","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00492.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00895.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01072.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00709.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00640.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00653.x"},{"key":"e_1_2_6_29_2","first-page":"1419","article-title":"Effect of triple therapy or amoxicillin plus omeprazole or amoxicillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1\u2010year follow up period: a prospective, randomized, controlled study","volume":"90","author":"Saberi\u2010Firoozi M","year":"1995","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199810000-00006"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199907000-00004"},{"key":"e_1_2_6_32_2","first-page":"1787","article-title":"Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non\u2010ulcer dyspepsia","volume":"15","author":"Gisbert JP","year":"2001","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"2","key":"e_1_2_6_33_2","first-page":"A79","article-title":"Cag negative status. A risk factor for failure of Helicobacter pylori triple therapies in non\u2010ulcer dyspepsia","volume":"43","author":"Broutet N","year":"1998","journal-title":"Gut"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409091402"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.3.321"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.6.845"},{"key":"e_1_2_6_37_2","first-page":"6","article-title":"Prevalence of Helicobacter pylori in two Iranian provinces with high and low incidence of gastric carcinoma","volume":"3","author":"Mikaeli J","year":"2000","journal-title":"Arch. Iranian Med."}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1440-1746.2003.02897.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1440-1746.2003.02897.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T21:11:23Z","timestamp":1697317883000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1440-1746.2003.02897.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,20]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1046\/j.1440-1746.2003.02897.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1440-1746.2003.02897.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12,20]]},"assertion":[{"value":"2002-12-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}